Modified Ross Score for Evaluation of Heart Failure in Children
1 other identifier
observational
100
0 countries
N/A
Brief Summary
- Identification of Patient those at risk For heart failure associated with lower respiratory tract infection
- Assess the value of Ross score evaluation in lower respiratory tract infection complicated with HF, as a diagnostic tool for severity of HF
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2019
CompletedFirst Posted
Study publicly available on registry
March 21, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedMarch 21, 2019
March 1, 2019
7 months
March 16, 2019
March 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The mean score in the study population
Modified Ross Score For Evaluation of Heart Failure in Children with Lower Respiratory Tract Infection Admitted To Assiut University Pediatric Hospital
1 hour
Interventions
modified score used for evaluation of heart failure in children, as a diagnostic tool for severity of heart failure
Eligibility Criteria
Infants and children around age of (1month to 18 years old) admitted in the Intensive Care Unit and Intermediate Care Unit in Assiut Pediatric Hospital in a period of 6 months
You may qualify if:
- Children with respiratory lower tract infection
You may not qualify if:
- Patients with past history of cardiac disease
- Patients with past history of renal disease.
- Patient less than 1 month
- Parent refusal to participate the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Laer S, Mir TS, Behn F, Eiselt M, Scholz H, Venzke A, Meibohm B, Weil J. Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. Am Heart J. 2002 May;143(5):916-22. doi: 10.1067/mhj.2002.121265.
PMID: 12040358BACKGROUNDRoss RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012 Dec;33(8):1295-300. doi: 10.1007/s00246-012-0306-8. Epub 2012 Apr 5.
PMID: 22476605BACKGROUNDRoss RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992 Apr;13(2):72-5. doi: 10.1007/BF00798207.
PMID: 1614922BACKGROUNDCorrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012 Feb 14;125(6):773-81. doi: 10.1161/CIRCULATIONAHA.111.040766. Epub 2012 Jan 4.
PMID: 22219349BACKGROUNDMusher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007 Jul 15;45(2):158-65. doi: 10.1086/518849. Epub 2007 Jun 6.
PMID: 17578773BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 16, 2019
First Posted
March 21, 2019
Study Start
November 1, 2019
Primary Completion
May 30, 2020
Study Completion
September 30, 2020
Last Updated
March 21, 2019
Record last verified: 2019-03